1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Neurovascular Devices Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Cerebral Embolization and Aneurysm Coiling Devices
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Embolic Coils
6.1.2.2 Flow Diverters
6.1.2.3 Liquid Embolic Agents
6.1.3 Market Forecast
6.2 Cerebral Angioplasty and Stenting Systems
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Carotid Artery Stents
6.2.2.2 Embolic Protection Devices
6.2.3 Market Forecast
6.3 Neurothrombectomy Devices
6.3.1 Market Trends
6.3.2 Key Segments
6.3.2.1 Clot Retrieval Devices
6.3.2.2 Suction Devices
6.3.2.3 Vascular Snares
6.3.3 Market Forecast
6.4 Support Devices
6.4.1 Market Trends
6.4.2 Key Segments
6.4.2.1 Micro Catheters
6.4.2.2 Micro Guidewires
6.4.3 Market Forecast
7 Market Breakup by Application
7.1 Ischemic Stroke
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Aneurysm
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Arteriovenous Malformation and Fistulas (AVM)
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Stenosis
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Acandis GmbH
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Asahi Intecc Co. Ltd.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Imperative Care Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Integer Holdings Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Johnson & Johnson
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Medtronic plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 MicroPort Scientific Corporation
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Penumbra Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Perflow Medical Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Rapid Medical
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Stryker Corporation
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Terumo Corporation
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/